Table 4.
Incidences of risk factors for anticholinergic agents and glucagon in patients undergoing gastrointestinal endoscopy
| Risk (n = 1480) | |
|---|---|
| No risk | 49.9% (738) |
| Anticholinergic | 41.6% (616) |
| Glucagon | 3.8%* (56) |
| Anticholinergic & Glucagon | 4.7%** (70) |
All data were expressed as mean. Analyses were conducted using Fisher’s exact method (chi-square test).
*Anticholinergic Group vs Glucagon group (p<0.001)
**Anticholinergic Group vs Anticholinergic & Glucagon group (p<0.001)